Test Price
2,800 AED✅ Home Collection Available
HOXD13 Gene Syndactyly Type 1 Genetic Test (NGS) – 2,800 AED – Dubai Healthcare City
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‐accredited next‑generation sequencing.
Premium Logistics: Temperature‑controlled cold‑chain home collection with VIP mobile phlebotomy available daily 8 AM–11 PM (optional).
Clinical Guidance: Post‑test telephonic interpretation by a Consultant Medical Geneticist.
Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The HOXD13 gene syndactyly type 1 NGS test detects pathogenic variants in the HOXD13 gene that cause non‑syndromic syndactyly. Whole‑exon sequencing with deep coverage enables precise molecular diagnosis and informed genetic counseling for UAE families.
| Feature | HOXD13 NGS (Our Test) | Closest Alternative (Sanger) |
|---|---|---|
| Precision | >99.9% sensitivity for SNVs, indels | ~99% per targeted exon |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger sequencing of selected regions |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh – Consultant Medical Genetics (DHA Reg# 9294403):
“A genetic diagnosis carries profound meaning for families. This HOXD13 analysis must be interpreted alongside a detailed dysmorphology assessment, three‑generation pedigree, and clinical correlation. A pathogenic result opens the door to targeted surveillance and reproductive planning, not a predetermined fate.”
Clinical Advisory
Pre‑test genetic counseling with a certified genetic counselor is mandatory. Please do not alter any prescribed medications without first consulting your treating physician. Sample collection via venipuncture or saliva is safe and minimally invasive.
Exclusion Criteria & Emergency Red Flags
Exclusion Criteria:
- Incomplete genetic counseling session and pedigree documentation before sample collection.
- Insufficient or degraded DNA sample that fails internal quality control.
Emergency Red Flags (seek immediate medical attention):
- Acute respiratory distress, severe pain, or signs of infection unrelated to the test procedure.
- Unexplained bleeding or complications after sample collection.
Patient FAQ & Clinical Guidance
1. What is the HOXD13 gene syndactyly type 1 NGS test?
This advanced genetic test sequences the entire HOXD13 gene to identify pathogenic mutations responsible for non‑syndromic syndactyly type 1. It is used for diagnostic confirmation and to guide family‑based screening.
2. How should I prepare for the test?
Complete a pre‑test genetic counseling appointment to document a detailed pedigree and clinical history. Fasting is not required, and you may continue all prescribed medications unless directed otherwise by your physician.
3. When will I receive my results and what do they mean?
Results are available within 3–4 weeks. A telephonic consultation with the Consultant Medical Geneticist will explain the report. A pathogenic result confirms the clinical diagnosis and informs surveillance and reproductive options for at‑risk relatives.
UAE Regulatory & Data Privacy Adherence
Data Protection Framework: All patient data and genetic information are processed in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and informed consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Laboratory operations are conducted under DHA Facility License No. 1143. No data is shared with third parties without explicit patient authorization.
Clinical & Logistical Metadata
| Test Name | HOXD13 Gene Syndactyly Type 1 NGS (Whole Gene Sequencing) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (EDTA) or saliva (Oragene® kit) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Illumina platform |
| ICD‑10‑CM Code | Q70.0 (Syndactyly of fingers) |
| LOINC Code | 78043‑4 (HOXD gene targeted mutation analysis) |
| DHA Facility License & Address | License #1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians